Imperial College London: Communicable Diseases trials

The registry lists 11 Communicable Diseases studies with Imperial College London as lead sponsor. 1 are open to participants now and 7 have results posted.

Phase 3 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic HepatitisRecruitingNCT03069300Phase 3
• SARS-CoV-2 Human Challenge Characterisation StudyCompletedNCT04865237Not applicableResults posted
• Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)TerminatedNCT04664075Results posted
• Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIVCompletedNCT04587050Results posted
• Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory PathogensTerminatedNCT04431050Results posted
• Enhanced, Personalized and Integrated Care for Infection Management at the Point-Of-CareCompletedNCT04013737Results posted
• The Development of a Human Model of Respiratory Syncytial Virus InfectionCompletedNCT01349543Not applicableResults posted
• To Assess Neuroinflammation and Neurocognitive Function in Patients With Acute Hepatitis C and Chronic HIV Co-InfectionCompletedNCT00959166Not applicableResults posted
• Smart Catheter: A Novel Biosensor for Early Detection of Catheter Associated Urinary Tract InfectionCompletedNCT04315129Not applicable
• Prophylactic Closed Incision Negative Pressure Wound Therapy on Abdominal Wounds - Clinical and Economic PerspectivesWithdrawnNCT04110353Not applicable
• Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive InfectionsCompletedNCT00501150Not applicable